Fluocinolone Acetonide Implant for Patients suffering from chronic posterior non-infectious Uveitis

被引：0
|
作者：
Bitzer, Michaela
机构：
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2019年 / 236卷 / 07期
关键词：
D O I：
10.1055/a-0891-6002
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF INTRACTABLE POSTERIOR UVEITIS IN PEDIATRIC PATIENTS WITH THE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT (RETISERT)
    Patel, Chirag C.
    Mandava, Naresh
    Oliver, Scott C. N.
    Braverman, Rebecca
    Quiroz-Mercado, Hugo
    Olson, Jeffrey L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (03): : 537 - 542
  • [32] Fluocinolone acetonide intravitreal implant for uveitis affecting the posterior segment of the eye
    Jaffe, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U118 - U118
  • [33] The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis
    Biswas, Jyotirmay
    Tyagi, Mudit
    Agarwal, Manisha
    OPHTHALMOLOGY SCIENCE, 2024, 4 (01):
  • [34] Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi)-3-year results
    Jaffe, Glenn J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [35] Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Pouwels, Xavier G. L. V.
    Petersohn, Svenja
    Carrera, Vanesa Huertas
    Denniston, Alastair K.
    Chalker, Annette
    Raatz, Heike
    Armstrong, Nigel
    Shah, Dhwani
    Witlox, Willem
    Worthy, Gill
    Noake, Caro
    Riemsma, Rob
    Kleijnen, Jos
    Joore, Manuela A.
    PHARMACOECONOMICS, 2020, 38 (05) : 431 - 441
  • [36] Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Xavier G. L. V. Pouwels
    Svenja Petersohn
    Vanesa Huertas Carrera
    Alastair K. Denniston
    Annette Chalker
    Heike Raatz
    Nigel Armstrong
    Dhwani Shah
    Willem Witlox
    Gill Worthy
    Caro Noake
    Rob Riemsma
    Jos Kleijnen
    Manuela A. Joore
    PharmacoEconomics, 2020, 38 : 431 - 441
  • [37] CALM: 24-month retinal thickness outcomes from a real-world registry study of patients with chronic non-infectious uveitis affecting the posterior segment treated with the 0.18 mg fluocinolone acetonide intravitreal implant
    Lin, Phoebe
    Suhler, Eric B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [38] Safety and efficacy of intravitreal triamcinolone acetonide in patients with non-infectious uveitis
    Letko, E
    Androudi, S
    Meniconi, M
    Papadaki, T
    Foster, CS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U331 - U331
  • [39] Fluocinolone acetonide 0.2 μg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations
    Pleyer, Uwe
    Pavesio, Carlos
    Miserocchi, Elisabetta
    Heinz, Carsten
    Devonport, Helen
    Llorenc, Victor
    Burke, Tomas
    Nogueira, Vanda
    Kodjikian, Laurent
    Bodaghi, Bahram
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2024, 14 (01):
  • [40] Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis
    Jaffe, Glenn J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (04) : 667 - 675
12345